Predictions
Zoetis Inc. A
Start price
Target price
Perf. (%)
€130.34
27.02.21
27.02.21
-
27.02.22
27.02.22
37.81%
20.01.22
20.01.22
Innovative
Medium risks for its business
Top 10 in its market
Future proof or reliable business model
Eastman Chemical Co.
Start price
Target price
Perf. (%)
€90.58
26.02.21
26.02.21
-
26.02.22
26.02.22
17.52%
27.02.22
27.02.22
High dividend yield expected
Revenue decline/stagnation expected
EBIT decline/stagnation expected
Intel Corp.
Start price
Target price
Perf. (%)
€49.51
26.02.21
26.02.21
€30.00
19.10.25
19.10.25
-58.57%
10.09.24
10.09.24
Innovative
Differentiated customer and product portfolio
Good culture
Well known brand
Alliance Data Systems Corp.
Start price
Target price
Perf. (%)
€74.60
25.02.21
25.02.21
-
25.02.22
25.02.22
10.86%
13.09.21
13.09.21
Below average Management
Probably not worthwhile Investment
Revenue decline/stagnation expected
EBIT decline/stagnation expected
Incyte Corp.
Start price
Target price
Perf. (%)
€64.63
25.02.21
25.02.21
€70.00
3.84%
08.03.21
08.03.21
Could be worthwhile Investment >10% per year
Mastercard Inc. A
Start price
Target price
Perf. (%)
€301.85
24.02.21
24.02.21
€305.00
5.52%
12.03.21
12.03.21
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
High dividend yield expected
Future proof or reliable business model
Advanced Micro Devices Inc.
Start price
Target price
Perf. (%)
€71.11
24.02.21
24.02.21
-
24.02.22
24.02.22
-9.20%
21.05.21
21.05.21
Meta Platforms Inc.
Start price
Target price
Perf. (%)
€218.20
24.02.21
24.02.21
€250.00
01.01.22
01.01.22
27.77%
25.10.21
25.10.21
DTE Energy Corp.
Start price
Target price
Perf. (%)
€101.00
24.02.21
24.02.21
€118.00
24.02.22
24.02.22
6.93%
25.02.22
25.02.22
Could be worthwhile Investment >10% per year
Undervalued
High dividend yield expected
positive Cash Flow expected
Crown Castle Internatl Corp.
Start price
Target price
Perf. (%)
€133.06
24.02.21
24.02.21
€100.00
24.02.22
24.02.22
24.76%
28.06.21
28.06.21
Probably not worthwhile Investment
overvalued
Higher risks for its business
Revenue decline/stagnation expected
Nasdaq OMX Group Inc.
Start price
Target price
Perf. (%)
€38.90
24.02.21
24.02.21
€41.67
24.02.22
24.02.22
30.25%
25.02.22
25.02.22
Could be worthwhile Investment >10% per year
Market Leader or Top 3
Well known brand
Future proof or reliable business model
Automatic Data Processing Inc
Start price
Target price
Perf. (%)
€144.92
24.02.21
24.02.21
€160.00
24.02.22
24.02.22
23.52%
25.02.22
25.02.22
Could be worthwhile Investment >10% per year
Good rating
Fair valuation
Very small cyclical dependencies
Stanley Black & Decker Inc.
Start price
Target price
Perf. (%)
€142.46
24.02.21
24.02.21
€130.00
24.02.22
24.02.22
19.44%
18.04.21
18.04.21
Probably not worthwhile Investment
High valuation
Low dividend yield expected
Significant cyclical dependencies
Fedex Corp.
Start price
Target price
Perf. (%)
€213.50
24.02.21
24.02.21
€230.00
24.02.22
24.02.22
-10.37%
25.02.22
25.02.22
Revenue growth >5% per year expected
Strong uniques
Low dividend yield expected
Little innovation
Incyte Corp.
Start price
Target price
Perf. (%)
€67.64
24.02.21
24.02.21
-
24.02.22
24.02.22
-12.39%
25.11.21
25.11.21
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Dependend from some customers or products
PepsiCo Inc.
Start price
Target price
Perf. (%)
€108.54
24.02.21
24.02.21
€102.00
3.10%
13.03.21
13.03.21
Known brand
Future proof or reliable business model
Top 10 in its market
Significant cyclical dependencies
Hologic Inc.
Start price
Target price
Perf. (%)
€62.50
24.02.21
24.02.21
-
24.02.22
24.02.22
1.60%
30.03.21
30.03.21
Probably not worthwhile Investment